R Boden

995 total citations
28 papers, 801 citations indexed

About

R Boden is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, R Boden has authored 28 papers receiving a total of 801 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in R Boden's work include Radiopharmaceutical Chemistry and Applications (20 papers), Monoclonal and Polyclonal Antibodies Research (18 papers) and Medical Imaging Techniques and Applications (4 papers). R Boden is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (20 papers), Monoclonal and Polyclonal Antibodies Research (18 papers) and Medical Imaging Techniques and Applications (4 papers). R Boden collaborates with scholars based in United Kingdom and United States. R Boden's co-authors include RB Pedley, Richard H. J. Beǵent, RHJ Begent, Aiden Flynn, G Boxer, Jason L.J. Dearling, R. Barbara Pedley, Geoffrey M. Boxer, Damian Marshall and Kerry Chester and has published in prestigious journals such as Cancer, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

R Boden

28 papers receiving 781 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Boden United Kingdom 17 529 353 200 130 89 28 801
Conrad Chan Canada 16 504 1.0× 213 0.6× 261 1.3× 60 0.5× 158 1.8× 32 772
Dietmar Berndorff Germany 14 548 1.0× 538 1.5× 326 1.6× 116 0.9× 76 0.9× 18 1.0k
Hitomi Sudo Japan 17 289 0.5× 246 0.7× 235 1.2× 100 0.8× 167 1.9× 56 766
Jacqueline Emrich United States 15 361 0.7× 231 0.7× 217 1.1× 57 0.4× 134 1.5× 34 822
Huiyun Zhao China 19 458 0.9× 254 0.7× 263 1.3× 65 0.5× 124 1.4× 38 894
Lawrence Lai United States 11 557 1.1× 308 0.9× 381 1.9× 54 0.4× 252 2.8× 12 1.2k
Alexander H. Staudacher Australia 15 355 0.7× 225 0.6× 443 2.2× 71 0.5× 141 1.6× 33 780
Sydney Welt United States 20 696 1.3× 680 1.9× 327 1.6× 115 0.9× 226 2.5× 35 1.3k
P A Keep United Kingdom 16 735 1.4× 483 1.4× 255 1.3× 39 0.3× 59 0.7× 22 952
David Woo United States 12 324 0.6× 304 0.9× 249 1.2× 31 0.2× 117 1.3× 36 739

Countries citing papers authored by R Boden

Since Specialization
Citations

This map shows the geographic impact of R Boden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Boden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Boden more than expected).

Fields of papers citing papers by R Boden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Boden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Boden. The network helps show where R Boden may publish in the future.

Co-authorship network of co-authors of R Boden

This figure shows the co-authorship network connecting the top 25 collaborators of R Boden. A scholar is included among the top collaborators of R Boden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Boden. R Boden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El‐Emir, Ethaar, Geoffrey M. Boxer, R Boden, et al.. (2005). Tumour parameters affected by combretastatin A-4 phosphate therapy in a human colorectal xenograft model in nude mice. European Journal of Cancer. 41(5). 799–806. 43 indexed citations
2.
Mayer, A, Aiden Flynn, RB Pedley, et al.. (2003). Higher Dose and Dose-Rate in Smaller Tumors Result in Improved Tumor Control. Cancer Investigation. 21(3). 382–388. 6 indexed citations
3.
Flynn, Aiden, RB Pedley, Alan J. Green, et al.. (2003). The Nonuniformity of Antibody Distribution in the Kidney and its Influence on Dosimetry. Radiation Research. 159(2). 182–189. 29 indexed citations
4.
Flynn, Aiden, Alan J. Green, R. Barbara Pedley, et al.. (2002). A model-based approach for the optimization of radioimmunotherapy through antibody design and radionuclide selection. Cancer. 94(S4). 1249–1257. 7 indexed citations
5.
Flynn, Aiden, RB Pedley, Ethaar El‐Emir, et al.. (2002). Spatial accuracy of 3D reconstructed radioluminographs of serial tissue sections and resultant absorbed dose estimates. Physics in Medicine and Biology. 47(20). 3651–3661. 2 indexed citations
6.
7.
Flynn, Aiden, RB Pedley, Alan J. Green, et al.. (2001). Optimizing Radioimmunotherapy by Matching Dose Distribution with Tumor Structure using 3D Reconstructions of Serial Images. Cancer Biotherapy and Radiopharmaceuticals. 16(5). 391–400. 9 indexed citations
8.
Chester, Kerry, et al.. (2000). Catalytic activity of anin vivo tumor targeted anti-CEA scFv::carboxypeptidase G2 fusion protein. International Journal of Cancer. 85(4). 571–577. 44 indexed citations
9.
Pedley, RB, et al.. (1999). Tumour targeting using MFE-23 :: TNF alpha fusion protein.. UCL Discovery (University College London). 1 indexed citations
10.
King, DJ, et al.. (1998). Clearance of yttrium-90-labelled anti-tumour antibodies with antibodies raised against the 12N4 DOTA macrocycle. British Journal of Cancer. 78(10). 1307–1312. 4 indexed citations
11.
Pedley, RB, R Boden, G Boxer, et al.. (1996). Ablation of colorectal xenografts with combined radioimmunotherapy and tumor blood flow-modifying agents.. UCL Discovery (University College London). 56(14). 3293–300. 67 indexed citations
12.
13.
Delgado, Cristina, RB Pedley, Ángel Herráez, et al.. (1996). Enhanced tumour specificity of an anti-carcinoembrionic antigen Fab' fragment by poly(ethylene glycol) (PEG) modification. British Journal of Cancer. 73(2). 175–182. 53 indexed citations
14.
Marshall, Damian, et al.. (1995). Galactosylated streptavidin for improved clearance of biotinylated intact and F(ab')2 fragments of an anti-tumour antibody. British Journal of Cancer. 71(1). 18–24. 31 indexed citations
15.
Marshall, Damian, et al.. (1994). Clearance of circulating radio-antibodies using streptavidin or second antibodies in a xenograft model. British Journal of Cancer. 69(3). 502–507. 25 indexed citations
16.
Turner, Alison, DJ King, RB Pedley, et al.. (1994). Comparative biodistributions of indium-111-labelled macrocycle chimeric B72.3 antibody conjugates in tumour-bearing mice. British Journal of Cancer. 70(1). 35–41. 9 indexed citations
17.
Beǵent, Richard H. J., et al.. (1994). Enhancement of radioimmunotherapy by drugs modifying tumour blood flow in a colonic xenograft model. International Journal of Cancer. 57(6). 830–835. 18 indexed citations
18.
Boden, R, et al.. (1993). Comparative radioimmunotherapy using intact or F(ab')2 fragments of 131I anti-CEA antibody in a colonic xenograft model. British Journal of Cancer. 68(1). 69–73. 53 indexed citations
19.
Pedley, R. Barbara, et al.. (1991). The effect of radiosensitizers on radio‐immunotherapy, using 131I‐Labelled anti‐cea antibodies in a human colonic xenograft model. International Journal of Cancer. 47(4). 597–602. 17 indexed citations
20.
Pedley, R. Barbara, et al.. (1989). The effect of serum CEA on the distribution and clearance of anti-CEA antibody in a pancreatic tumour xenograft model. British Journal of Cancer. 60(4). 549–554. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Conrad Chan Breakdown of academic impact, for papers by Dietmar Berndorff Breakdown of academic impact, for papers by Hitomi Sudo Breakdown of academic impact, for papers by Jacqueline Emrich Breakdown of academic impact, for papers by Huiyun Zhao Breakdown of academic impact, for papers by Lawrence Lai Breakdown of academic impact, for papers by Alexander H. Staudacher Breakdown of academic impact, for papers by Sydney Welt Breakdown of academic impact, for papers by P A Keep Breakdown of academic impact, for papers by David Woo
Rankless by CCL
2026